EP
Eversept Partners Portfolio holdings
AUM
$992M
This Quarter Return
-5.42%
1 Year Return
+2.54%
3 Year Return
+103.47%
5 Year Return
+181.01%
10 Year Return
–
AUM
$319M
AUM Growth
+$319M
(-8.8%)
Cap. Flow
+$2.02M
Cap. Flow
% of AUM
0.63%
Top 10 Holdings %
Top 10 Hldgs %
63.37%
Holding
71
New
10
Increased
20
Reduced
18
Closed
16
Top Buys
| 1 |
The Ensign Group
ENSG
|
$13.3M |
| 2 |
GSK
GSK
|
$12.5M |
| 3 |
Ascendis Pharma
ASND
|
$9.63M |
| 4 |
Envista
NVST
|
$8.87M |
| 5 |
DexCom
DXCM
|
$6.65M |
Top Sells
| 1 |
RCM
R1 RCM Inc. Common Stock
RCM
|
$17.6M |
| 2 |
DCPH
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
|
$9.61M |
| 3 |
RDUS
Radius Health, Inc.
RDUS
|
$9.42M |
| 4 |
eHealth
EHTH
|
$9.09M |
| 5 |
NUVA
NuVasive, Inc.
NUVA
|
$5.37M |
Sector Composition
| 1 | Healthcare | 87.73% |
| 2 | Real Estate | 4.64% |
| 3 | Industrials | 2.03% |
| 4 | Communication Services | 1.05% |
| 5 | Financials | 0.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
BDSI
26
DELISTED
BioDelivery Sciences International, Inc.
BDSI
| $2.98M | 0.92% |
708,020
+351,746
| +99% | +$1.48M |
|
|
ARQL
27
DELISTED
Arqule Inc
ARQL
| $2.96M | 0.92% |
412,388
-39,300
| -9% | -$282K |
|
|
HSKA
28
DELISTED
Heska Corp
HSKA
| $2.89M | 0.9% |
40,824
+5,900
| +17% | +$418K |
|
|
29
eHealth
EHTH
$126M
| $2.85M | 0.88% |
42,653
-136,086
| -76% | -$9.09M |
|
30
Community Health Systems
CYH
$392M
| $2.19M | 0.68% |
+607,383
| New | +$2.19M |
|
31
Fate Therapeutics
FATE
$115M
| $2.18M | 0.68% |
140,656
-77,200
| -35% | -$1.2M |
|
32
Cytokinetics
CYTK
$5.98B
| $2.07M | 0.64% |
+181,700
| New | +$2.07M |
|
|
TCDA
33
DELISTED
Tricida, Inc. Common Stock
TCDA
| $2.02M | 0.63% |
65,568
-22,000
| -25% | -$679K |
|
34
MacroGenics
MGNX
$121M
| $1.98M | 0.61% |
154,824
-35,799
| -19% | -$457K |
|
35
Xenon Pharmaceuticals
XENE
$2.99B
| $1.94M | 0.6% |
215,609
-8,731
| -4% | -$78.7K |
|
36
Apellis Pharmaceuticals
APLS
$3.51B
| $1.92M | 0.59% |
79,509
-37,800
| -32% | -$911K |
|
37
BioCryst Pharmaceuticals
BCRX
$1.74B
| $1.88M | 0.58% |
654,460
+312,000
| +91% | +$894K |
|
38
Collegium Pharmaceutical
COLL
$1.25B
| $1.84M | 0.57% |
160,295
+19,295
| +14% | +$222K |
|
39
scPharmaceuticals
SCPH
$296M
| $1.3M | 0.4% |
221,636
+47,339
| +27% | +$278K |
|
|
AGRX
40
DELISTED
Agile Therapeutics, Inc
AGRX
| $1.08M | 0.33% |
+909,485
| New | +$1.08M |
|
|
IVC
41
DELISTED
Invacare Corporation
IVC
| $970K | 0.3% |
129,361
-80,922
| -38% | -$607K |
|
|
AFMD
42
DELISTED
Affimed
AFMD
| $947K | 0.29% |
322,171
| – | – |
|
|
OTIC
43
DELISTED
Otonomy, Inc.
OTIC
| $899K | 0.28% |
376,342
+181,913
| +94% | +$435K |
|
44
Codexis
CDXS
$218M
| $864K | 0.27% |
+63,000
| New | +$864K |
|
45
Savara
SVRA
$591M
| $839K | 0.26% |
316,679
+74,536
| +31% | +$198K |
|
|
DCPH
46
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $747K | 0.23% |
22,000
-283,233
| -93% | -$9.61M |
|
|
OPTN
47
DELISTED
OptiNose
OPTN
| $736K | 0.23% |
105,106
| – | – |
|
|
EIGR
48
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
| $715K | 0.22% |
69,708
| – | – |
|
|
DRNA
49
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $590K | 0.18% |
41,074
| – | – |
|
|
LUMO
50
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
| $434K | 0.13% |
+272,983
| New | +$434K |
|